Year: 2025
Type: article
Abstract: Nuclear drug delivery represents an advanced therapeutic approach focused on targeting the nucleus of cells to enhance treatment specificity and efficacy for complex diseases, including cancer and genetic disorders. This strategy integrates nanotechnology, molecular biology, and pharmacology to overcome intracellular barriers and precisely deliver therapeutic agents, such as DNA, RNA, or plasmids, to nuclear targets. Key mechanisms include nuclear localization signals (NLS), receptor-mediated transport, and stimuli-responsive delivery systems. Various nanoparticle platforms, including magnetic and gold nanoparticles, polymeric micelles, and lipid nanoparticles, provide multifunctionality, enabling both therapeutic delivery and diagnostic imaging. Despite significant progress, challenges remain in ensuring biocompatibility, minimizing off-target effects, and scaling up manufacturing. Continued advancements in biocompatible materials, multifunctional systems, and integration with emerging technologies like CRISPR-Cas9 hold promise for the future of precision medicine through nuclear-targeted therapies.
Source: The Bombay Technologist
Author: Isha S. Ingle
Institution: Institute of Chemical Technology
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: diamond
OpenAlex ID: W6947689293